Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 173961 - 173980 out of 566296 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Czech Republic | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS KRKA | 10MG, 10MG TBL NOB 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | Krka,d.d.,Novomesto,Novomesto |
| Czech Republic | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS MYLAN | 10MG, 10MG TBL NOB 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | MylanIrelandLimited,Dublin |
| Czech Republic | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS SANDOZ | 10MG, 10MG TBL NOB 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | Sandozs.r.o.,Praha |
| Czech Republic | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS VIPHARM | 10MG, 10MG TBL NOB 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | VipharmS.A.,OżarówMazowiecki |
| Czech Republic | (L01EG02) everolimus (neoplastic diseases) | VERIMMUS | 10MG, 10MG TBL NOB 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | EgisPharmaceuticalsPLC,Budapešť |
| Czech Republic | (L01EG02) everolimus (neoplastic diseases) | AFINITOR | 5MG, 5MG TBL NOB 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NovartisEuropharmLimited,Dublin |
| Czech Republic | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS KRKA | 5MG, 5MG TBL NOB 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | Krka,d.d.,Novomesto,Novomesto |
| Czech Republic | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS MYLAN | 5MG, 5MG TBL NOB 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | MylanIrelandLimited,Dublin |
| Czech Republic | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS SANDOZ | 5MG, 5MG TBL NOB 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | Sandozs.r.o.,Praha |
| Czech Republic | (L01EG02) everolimus (neoplastic diseases) | EVEROLIMUS VIPHARM | 5MG, 5MG TBL NOB 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | VipharmS.A.,OżarówMazowiecki |
| Czech Republic | (L01EG02) everolimus (neoplastic diseases) | VERIMMUS | 5MG, 5MG TBL NOB 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | EgisPharmaceuticalsPLC,Budapešť |
| Czech Republic | (L01EH01) lapatinib | TYVERB | 250MG, 250MG TBL FLM 70 , TBC | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisEuropharmLimited,Dublin |
| Czech Republic | (L01EH01) lapatinib | TYVERB | 250MG, 250MG TBL FLM 70 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisEuropharmLimited,Dublin |
| Czech Republic | (L01EH02) neratinib | NERLYNX | 40MG, 40MG TBL FLM 180 , TBC | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | PIERREFABREMEDICAMENT,Lavaur |
| Czech Republic | (L01EH03) tucatinib | TUKYSA | 150MG, 150MG TBL FLM 84 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms; Neoplasm Metastasis | SeagenB.V.,Schiphol |
| Czech Republic | (L01EH01) lapatinib | TYVERB | 250MG, 250MG TBL FLM 70 , TBC | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisEuropharmLimited,Dublin |
| Czech Republic | (L01EH01) lapatinib | TYVERB | 250MG, 250MG TBL FLM 70 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisEuropharmLimited,Dublin |
| Czech Republic | (L01EH02) neratinib | NERLYNX | 40MG, 40MG TBL FLM 180 , TBC | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | PIERREFABREMEDICAMENT,Lavaur |
| Czech Republic | (L01EJ01) ruxolitinib (adm: O) | JAKAVI | 15MG, 15MG TBL NOB 56 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NovartisEuropharmLimited,Dublin |
| Czech Republic | (L01EJ01) ruxolitinib (adm: O) | JAKAVI | 20MG, 20MG TBL NOB 56 , BLI | Retail price with vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NovartisEuropharmLimited,Dublin |
Pages
